Company news
EchoIQ Limited news in 2026
EchoIQ Limited's news releases, calls and decks from 2026, newest first.
Notification regarding unquoted securities - EIQ
November 4, 2026
Quarterly Activities Report & Appendix 4C Cashflow Report
October 25, 2026
Notice of Annual General Meeting/Proxy Form
October 23, 2026
Notification of cessation of securities - EIQ
October 22, 2026
EchoSolv HF FDA 510(k) update
October 11, 2026
Date of AGM and Closing Date for Director Nominations
October 6, 2026
EchoSolv HF FDA application update
September 16, 2026
Notification regarding unquoted securities - EIQ
September 14, 2026
Cleansing Notice
September 10, 2026
Application for quotation of securities - EIQ
September 10, 2026
Investor Webinar
September 8, 2026
EchoSolv HF FDA Application Update
September 8, 2026
Trading Halt
September 6, 2026
Pause in Trading
September 6, 2026
Notification of cessation of securities - EIQ
September 4, 2026
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
Proposed issue of securities - EIQ
September 1, 2026
Initial Director's Interest Notice - Scott Wilkin
September 1, 2026
Global healthcare investment leader appointed to Board
August 31, 2026
Appendix 4G and Corporate Governance Statement
August 27, 2026
Annual Report to Shareholders
August 27, 2026
Preliminary Final Report
August 27, 2026
Cleansing Notice
August 21, 2026
Application for quotation of securities - EIQ
August 21, 2026
Convertible note executed with Pro Medicus
August 16, 2026
Cleansing Notice
August 7, 2026
Application for quotation of securities - EIQ
August 7, 2026
Investor Webinar
July 27, 2026
Quarterly Activities Report & Appendix 4C Cashflow Report
July 26, 2026
Exclusive Imaging Dataset Strengthens AI Competitive Moat
July 1, 2026
Echo IQ Raises A$110m via Institutional Placement
June 30, 2026
Binding HOA secured with Pro Medicus Limited
June 24, 2026
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
June 24, 2026
Research collaboration secured with Mayo Clinic
June 11, 2026
$762k R&D Tax Incentive Received
May 25, 2026
Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
April 30, 2026
QuarterlyActivities Report and Appendix 4C Cash Flow Report
April 29, 2026
EchoSolv AS deployed into Mount Sinai Health System
April 27, 2026
Agreement with Mayo Clinic for EchoSolv HF
March 23, 2026
Update - S&P DJI March 2026 Rebalance of the All Ordinaries
March 10, 2026
S&P DJI Announces March 2026 Quarterly Rebalance
March 6, 2026
Appendix 4D 31 December 2025
February 26, 2026
Quarterly Activities Report and Appendix 4C Cash Flow Report
January 23, 2026
Response to ASX Price Query
January 22, 2026